How Can Liquid Biomarkers Reduce Prostate Cancer Overtreatment?

New research reveals that liquid biomarkers—measured through simple blood and urine tests—are revolutionizing prostate cancer care. By detecting disease progression early, they help prevent overtreatment and ensure timely, targeted therapies for metastatic cases. Discover how these cutting-edge tests are reshaping prostate cancer care. keep reading